| # | Title | Journal | Year | Citations |
|---|
| 1 | Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer | JAMA Oncology | 2018 | 190 |
| 2 | Hyaluronan, Inflammation, and Breast Cancer Progression | Frontiers in Immunology | 2015 | 164 |
| 3 | Tunneling nanotubes promote intercellular mitochondria transfer followed by increased invasiveness in bladder cancer cells | Oncotarget | 2017 | 109 |
| 4 | The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial | Lancet, The | 2022 | 89 |
| 5 | Prostate extracellular vesicles in patient plasma as a liquid biopsy platform for prostate cancer using nanoscale flow cytometry | Oncotarget | 2016 | 80 |
| 6 | Role of endolaryngeal surgery (with or without laser) versus radiotherapy in the management of early (T1) glottic cancer: A systematic review | Head and Neck | 2014 | 79 |
| 7 | OATP1B1 and tumour OATP1B3 modulate exposure, toxicity, and survival after irinotecan-based chemotherapy | British Journal of Cancer | 2015 | 67 |
| 8 | Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non–Small Cell Lung Cancer | JAMA Oncology | 2019 | 67 |
| 9 | Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study | European Urology | 2021 | 65 |
| 10 | Functional lung avoidance for individualized radiotherapy (FLAIR): study protocol for a randomized, double-blind clinical trial | BMC Cancer | 2014 | 49 |
| 11 | Outcomes of Cutaneous Squamous Cell Carcinoma in the Head and Neck Region With Regional Lymph Node Metastasis | JAMA Otolaryngology - Head and Neck Surgery | 2019 | 47 |
| 12 | A Systematic Analysis of Negative Growth Control Implicates the DREAM Complex in Cancer Cell Dormancy | Molecular Cancer Research | 2017 | 40 |
| 13 | Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma | JAMA Oncology | 2022 | 38 |
| 14 | Three-dimensional-guided perineal-based interstitial brachytherapy in cervical cancer: A systematic review of technique, local control and toxicities | Radiotherapy and Oncology | 2017 | 34 |
| 15 | Evaluating organ preservation outcome as treatment endpoint for T1aN0 glottic cancer | Laryngoscope | 2017 | 34 |
| 16 | Bone Health and Bone-targeted Therapies for Prostate Cancer: a Programme in Evidence-based Care — Cancer Care Ontario Clinical Practice Guideline | Clinical Oncology | 2017 | 33 |
| 17 | BRCA2 inhibition enhances cisplatin‐mediated alterations in tumor cell proliferation, metabolism, and metastasis | Molecular Oncology | 2014 | 32 |
| 18 | Optimizing PSMA Radioligand Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Meta-Analysis | International Journal of Molecular Sciences | 2020 | 32 |
| 19 | A Pilot Study Comparing HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas by Whole Exome Sequencing | ISRN Oncology | 2012 | 31 |
| 20 | Canadian guideline on genetic screening for hereditary renal cell cancers | Canadian Urological Association Journal | 2013 | 30 |
| 21 | TBX3 promotes progression of pre‐invasive breast cancer cells by inducing EMT and directly up‐regulating SLUG | Journal of Pathology | 2019 | 28 |
| 22 | Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patients | Oral Oncology | 2019 | 28 |
| 23 | IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer Cells | PLoS ONE | 2015 | 27 |
| 24 | Tamoxifen-associated hot flash severity is inversely correlated with endoxifen concentration and CYP3A4*22 | Breast Cancer Research and Treatment | 2014 | 26 |
| 25 | Adjuvant Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (TKIs) in Resected Non–Small Cell Lung Cancer (NSCLC) | American Journal of Clinical Oncology: Cancer Clinical Trials | 2019 | 25 |
| 26 | The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer | BMC Cancer | 2016 | 23 |
| 27 | High-dose-rate interstitial brachytherapy for the treatment of high-volume locally recurrent endometrial carcinoma | Brachytherapy | 2016 | 23 |
| 28 | Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potential | BMC Cancer | 2017 | 23 |
| 29 | Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer | Pharmacogenomics Journal | 2020 | 22 |
| 30 | Predictors of Survival Benefit From Immune Checkpoint Inhibitors in Patients With Advanced Non–small-cell Lung Cancer: A Systematic Review and Meta-analysis | Clinical Lung Cancer | 2020 | 22 |
| 31 | Cost-Effectiveness of First-Line Treatments for Patients with Kras Wild-Type Metastatic Colorectal Cancer | Current Oncology | 2014 | 21 |
| 32 | Utilizing Artificial Intelligence for Head and Neck Cancer Outcomes Prediction From Imaging | Canadian Association of Radiologists Journal | 2021 | 21 |
| 33 | Effect of dataset size, image quality, and image type on deep learning-based automatic prostate segmentation in 3D ultrasound | Physics in Medicine and Biology | 2022 | 21 |
| 34 | The impact of PSMA PET on the treatment and outcomes of men with biochemical recurrence of prostate cancer: a systematic review and meta-analysis | Prostate Cancer and Prostatic Diseases | 2023 | 21 |
| 35 | Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: a systematic review | Canadian Urological Association Journal | 2013 | 20 |
| 36 | Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trial | BMC Cancer | 2019 | 20 |
| 37 | Management of colorectal cancer with synchronous liver metastases: impact of multidisciplinary case conference review | Hepatobiliary Surgery and Nutrition | 2017 | 19 |
| 38 | Genome-wide analysis reveals a role for TDG in estrogen receptor-mediated enhancer RNA transcription and 3-dimensional reorganization | Epigenetics and Chromatin | 2018 | 19 |
| 39 | Feedback from health professionals in postgraduate medical education: Influence of interprofessional relationship, identity and power | Medical Education | 2021 | 19 |
| 40 | Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models | PLoS ONE | 2018 | 18 |
| 41 | Optimal sequence of adjuvant endocrine and radiation therapy in early-stage breast cancer – A systematic review | Cancer Treatment Reviews | 2018 | 18 |
| 42 | The Standardization of Outpatient Procedure (STOP) Narcotics: A Prospective Health Systems Intervention to Reduce Opioid Use in Ambulatory Breast Surgery | Annals of Surgical Oncology | 2019 | 18 |
| 43 | Identification and characterization of multiple conserved nuclear localization signals within adenovirus E1A | Virology | 2014 | 16 |
| 44 | Secular Trends in the Survival of Patients with Laryngeal Carcinoma, 1995–2007 | Current Oncology | 2015 | 16 |
| 45 | Survival Outcome Differences Based on Treatments Used and Knowledge of the Primary Tumour Site for Patients with Cancer of Unknown and Known Primary in Ontario | Current Oncology | 2018 | 16 |
| 46 | Dosimetric Evaluation of PSMA PET-Delineated Dominant Intraprostatic Lesion Simultaneous Infield Boosts | Advances in Radiation Oncology | 2020 | 16 |
| 47 | Colon cancer care and survival: income and insurance are more predictive in the USA, community primary care physician supply more so in Canada | International Journal for Equity in Health | 2015 | 15 |
| 48 | Constitutional Epi/Genetic Conditions: Genetic, Epigenetic, and Environmental Factors | Journal of Pediatric Genetics | 2017 | 15 |
| 49 | Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival | Cancers of the Head & Neck | 2019 | 15 |
| 50 | Multiplicative disadvantage of being an unmarried and inadequately insured woman living in poverty with colon cancer: historical cohort exploration in California | BMC Women's Health | 2015 | 14 |
